Galderma Study Links Injectables to Menopausal Skin
New research details how combination treatments can increase dermal thickness in skin affected by menopause.
Updated on Oct. 16, 2026 in Beauty
Live Poll
Do you trust that cosmetic injectables are an effective way to manage menopausal skin changes?
Galderma has published findings from an eight-month trial exploring the efficacy of combining Restylane Skinboosters and Sculptra for menopausal skin. The study highlights significant improvements in facial dermal thickness through sequenced injectable protocols.
Why it matters
The research addresses a critical knowledge gap regarding the distinction between standard aging and hormonal skin changes during menopause. By identifying effective treatment protocols, the findings aim to better inform the skincare decisions of millions of women.
Trial participants reported a 27.3% increase in facial dermal thickness when treated with Restylane Skinboosters followed by Sculptra. Additionally, 98% of patients reported natural-looking results, while 92% indicated they would repeat the treatment.
The players
Galderma
Galderma is a dermatology-focused company that manufactures injectable aesthetics and skincare products.
The details
The clinical study focused on two distinct treatment sequences to enhance hydration and stimulate collagen production. Patients reported high satisfaction, with 96% of participants stating they would recommend the combined protocol to others.
Timeline
The research findings were released on October 16, 2026.
World Menopause Day takes place on October 18, 2026.
Culture Shift
This study aligns with the growing consumer demand for menopause-specific skincare products by providing clinical data to support purchase decisions. It marks a shift from general anti-aging marketing toward specialized, science-backed protocols for menopausal skin changes.
For consumers, these findings provide a basis for discussing targeted hormonal skin concerns with professional dermatologists or aesthetic clinicians. Understanding the efficacy of specific injection sequences can help patients make more informed choices about their long-term skincare budgets.
The takeaway
Women increasingly prioritize products that address the specific physiological changes associated with perimenopause and menopause. Consulting with a qualified provider remains the best way to determine if sequenced injectable treatments align with your specific skin goals.
Further reading
Learn more about the latest developments in Beauty research and clinical skin protocols.
Live Poll
Do you trust that cosmetic injectables are an effective way to manage menopausal skin changes?
